Adhera Therapeutics ROA 2024

Adhera Therapeutics Aktienanalyse

What does Adhera Therapeutics do?

Adhera Therapeutics Inc was founded in California in 2015 and is a biopharmaceutical company that focuses on researching, developing, and commercializing therapeutics for the treatment of metabolic diseases. Translation: Adhera Therapeutics Inc was founded in California in 2015 and is a biopharmaceutical company that focuses on researching, developing, and commercializing therapeutics for the treatment of metabolic diseases. The history of Adhera Therapeutics Inc began with the goal of developing innovative and effective treatment options for metabolic diseases such as diabetes or high cholesterol levels. The company has utilized its expertise in drug development to explore novel therapeutics and medications that meet the needs of patients and improve their quality of life. Adhera Therapeutics Inc specializes in three main areas: diabetes, obesity, and cardiovascular diseases. Within these areas, the company has developed a variety of products aimed at lowering blood sugar and cholesterol levels, increasing insulin sensitivity, reducing appetite, and controlling body weight. The business model of Adhera Therapeutics Inc is based on the development of high-quality medications and therapies specifically tailored to the needs of patients with metabolic diseases. The company utilizes innovative technologies, advanced research methods, and sound scientific knowledge to develop medications that demonstrate high efficacy and clinical safety. Adhera Therapeutics Inc has introduced a variety of products to the market specifically developed for different types of metabolic diseases. These include insulin sensitizers that lower blood sugar levels and increase insulin sensitivity, which can be used in the treatment of type 2 diabetes. Another product is a GLP-1 agonist that contributes to appetite control and is used in the treatment of obesity. Adhera Therapeutics Inc has also developed a long-acting preparation that is administered weekly and can be used in the combination treatment of type 2 diabetes and obesity. The medication aims to lower both blood sugar levels and body weight while improving insulin sensitivity and reducing the risk of complications in diabetes. The company has also developed a medication for the treatment of hyperlipidemia that aims to reduce high cholesterol levels and lower the risk of cardiovascular diseases. Overall, Adhera Therapeutics Inc has developed an impressive range of products aimed at meeting the needs of patients with metabolic diseases and improving their quality of life. The company has conducted extensive scientific research and clinical studies to demonstrate the effectiveness and safety of its products. Adhera Therapeutics Inc has now achieved a strong position in the metabolic disease market and will continue to be innovative in exploring and developing new therapeutics and medications that improve the health of patients worldwide. Adhera Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Adhera Therapeutics's Return on Assets (ROA)

Adhera Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Adhera Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Adhera Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Adhera Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Adhera Therapeutics stock

What is the Return on Assets (ROA) of Adhera Therapeutics this year?

The Return on Assets (ROA) of Adhera Therapeutics is -34.61 undefined this year.

What was the ROA of Adhera Therapeutics compared to the previous year?

The ROA of Adhera Therapeutics has increased by -19.3% compared to the previous year.

What consequences do high ROA have for investors of Adhera Therapeutics?

A high ROA is advantageous for investors of Adhera Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Adhera Therapeutics?

A low ROA can be unfavorable for investors of Adhera Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Adhera Therapeutics affect the company?

An increase in ROA of Adhera Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Adhera Therapeutics impact the company?

A reduction in the ROA of Adhera Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Adhera Therapeutics?

Some factors that can influence the ROA of Adhera Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Adhera Therapeutics important for investors?

The ROA of Adhera Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Adhera Therapeutics take to improve ROA?

To improve ROA, Adhera Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Adhera Therapeutics pay?

Over the past 12 months, Adhera Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Adhera Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Adhera Therapeutics?

The current dividend yield of Adhera Therapeutics is .

When does Adhera Therapeutics pay dividends?

Adhera Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Adhera Therapeutics?

Adhera Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Adhera Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Adhera Therapeutics located?

Adhera Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Adhera Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Adhera Therapeutics from 11/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Adhera Therapeutics pay the last dividend?

The last dividend was paid out on 11/15/2024.

What was the dividend of Adhera Therapeutics in the year 2023?

In the year 2023, Adhera Therapeutics distributed 0 USD as dividends.

In which currency does Adhera Therapeutics pay out the dividend?

The dividends of Adhera Therapeutics are distributed in USD.